Picture of aap Implantate AG logo

AAQ1 aap Implantate AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Aap Q3 EBITDA Loss Widens To EUR 1.7 Million

Nov 14 (Reuters) - AAP IMPLANTATE AG  AAQG.DE :
    * SOLID Q3/2019 WITH SALES AND EBITDA IN LINE WITH
EXPECTATIONS;
SALES GROWTH AND IMPROVED RECURRING EBITDA IN 9M/2019
    * RECORDED SALES AND EBITDA IN LINE WITH EXPECTATIONS IN Q3
OF
2019
    * Q3 SALES OF EUR 2.7 MILLION (Q3/2018: EUR 2.7 MILLION)
    * Q3 EBITDA AMOUNTED TO EUR -1.7 MILLION (Q3/2018: EUR -1.5
MILLION) AND
    * FOR 2019 FINANCIAL YEAR, MANAGEMENT BOARD CONTINUES TO
EXPECT
SALES OF BETWEEN EUR 11.0 MILLION AND EUR 13.0 MILLION
    * FOR 2019, CONTINUES TO EXPECT EBITDA OF BETWEEN EUR -6.0
MILLION
AND EUR -5.0 MILLION

Source text for Eikon:  ID:nEQbMl5fDa 
Further company coverage:  AAQG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on aap Implantate AG

See all news